Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Pregnant women who lived near recreational use cannabis retailers were more likely to use cannabis early in their pregnancies, new Kaiser Permanente research found.
A detailed analysis of mental health treatment trends during the COVID-19 pandemic found a 7% increase in visits during the initial shelter-in-place period in 2020, compared with the same 3-month period in 2019.
Kaiser Permanente study, believed to be the first to look at hormone therapy initiation and adherence in this population, suggests lower rates of use may be contributing to higher breast cancer death rates.
KP Research Radio spoke with cardiovascular research scientists Alan Go, MD, and Andrew Ambrosy, MD, about research aimed at improving care for people with heart failure.
Kaiser Permanente study finds regular moderate-to-vigorous exercise in the months following a breast cancer diagnosis has bone benefits.
An analysis of Kaiser Permanente members in Northern California early in the COVID-19 pandemic found racial and ethnic disparities in the likelihood of testing positive for the coronavirus, but no significant disparities in mortality among those who were hospitalized.
Kaiser Permanente research shows 2-fold higher risk for heart artery calcification after pregnancy through mid-life, even in women with normal blood sugar levels.
Black patients with heart failure have higher rates of hospitalization for heart failure but lower rates of death than white patients with heart failure, a new Kaiser Permanente study shows.
Kaiser Permanente’s Vaccine Study Center is leading a key part of the national safety surveillance effort for the COVID-19 vaccines, tracking patient data for serious side effects.
New study is first to quantify and compare the effects of long-term exposure to small particle pollution on risk for different types of cardiovascular disease.